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Abstract Outcomes in critically ill neonates have im-
proved over the past three decades, yet high residual
mortality and morbidity rates exist. Acute kidney injury
(AKI) is not just an innocent by-stander in the critically ill
patient. Research on incidence and outcomes of AKI in the
critically ill neonatal population is scarce. The objective of
this publication is to (a) review original articles on the
short- and long-term outcomes after neonatal AKI, (b)
highlight key articles on adults and children with AKI in
order to demonstrate how such insights might be applied to
neonates, and (c) suggest clinical research studies to fill the
gaps in our understanding of neonatal AKI. To date,
observational studies suggest high rates of AKI and poor
outcomes in critically ill neonates. Neonates with AKI are
at risk of developing chronic kidney disease and hyperten-
sion. Large prospective studies are needed to test defini-
tions and to better understand risk factors, incidence,
independent outcomes, and mechanisms that lead to poor
short- and long-term outcomes. Early biomarkers of AKI
need to be explored in critically ill neonates. Infants with
AKI need to be followed for sequelae after AKI.
Keywords Renalfailure.Outcomes.Biomarker.Neonate.
Premature.Chronic
Introduction
Advancements in neonatal–perinatal medicine have im-
proved the survival rates of critically ill neonates, yet
residual mortality and morbidity rates are significant [1].
Acute kidney injury (AKI) is a complex disorder with
clinical manifestations ranging from mild dysfunction to
complete anuric kidney failure. Our understanding of the
epidemiology of neonatal AKI is based on small single-
center studies that usually focus on a subset of the
neonatal population. Nonetheless, the available data
suggest that the incidence of AKI in asphyxiated neonates
is high, that non-oliguric AKI is common, and that AKI
portends poor outcomes [2–6]. Few articles on other
critically ill infants are limited to retrospective cross-
sectional studies or prospective studies with poor defini-
tions of AKI [5, 7, 8] (reviewed below). The independent
impact of AKI on outcomes has not been explored,
probably due to limitations of sample size and lack of a
consistent definition.
Novel urinary biomarkers can diagnose AKI within
hours of an insult have been discovered. The original
experience with several of these biomarkers occurred in
neonates who required cardiopulmonary bypass surgery.
Studies to detect AKI in non-cardiac critically ill neonates
have not been performed. These biomarkers will change
our approach to the diagnosis AKI and, hopefully, lead to
better preventative and therapeutic interventions which will
improve outcomes of critically ill neonates.
Rodriguez et al. [9] showed that the extra-uterine
environment is not optimal for glomerular development,
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Mounting evidence shows that premature infants are at risk
of hypertension, chronic kidney disease and metabolic
syndrome. In addition, after hospitalization for AKI, adults
and children are at risk of death or chronic kidney disease
(CKD). Thus, premature infants with AKI are at risk for
CKD [4, 10].
Publications on neonatal AKI and key pediatric and
adult AKI will be used to explain our current understanding
of the diagnosis, incidence, outcomes, and potential role of
biomarkers in early detection of neonatal AKI. Research
priorities to fill the gaps in our current understanding will
be suggested.
Definition of acute kidney injury
Acute kidney injury is a complex disorder that occurs with
variable severity and in many clinical scenarios. Until
recently, lack of universally recognized definition of AKI
limited our ability to compare studies, predict clinical
courses, and improve outcomes. In 2004, nephrology and
critical care groups recognized these limitations and pro-
posed an empiric working AKI definition [11] (Table 1):
The RIFLE (risk, injury, failure, loss, and end-stage renal
disease) classification has been studied extensively in
several adult populations whereby a change in renal
function and/or the presence of oliguria fulfills criteria
[12, 13]. Using these AKI classification definitions, studies
of critically ill pediatric and adult patients consistently
show that AKI has an independent impact upon survival
after correction for co-morbidities, complications and
severity of illness [14, 15]. These data suggest that patients
may not only die with kidney failure but that this
dysfunction causes functional and transcriptional changes
in the lung and other organs that ultimately lead to poor
outcomes [13]. These studies have not been reproduced in
critically ill neonatal populations.
In March 2007 the Acute Kidney Injury Network
(AKIN), a collaborative group of investigators from all
major critical care and nephrology societies, proposed a
staging system which use mild AKI (stage 1), moderate
AKI (stage 2) and severe AKI (stage 3) in a way similar to
the risk, injury and failure categories in RIFLE [16]. The
major changes from RIFLE include decreasing the change
in serum creatinine (SCr) threshold (0.3 mg/dl) to be
classified as mild AKI, and classifying anyone on dialysis
as having class 3 AKI (Table 1). In addition, the AKIN
criteria include a time requirement to denote the acute
changes in kidney function, where changes need to be
abrupt: within 48 h (Table 1).
In children, Akcan-Arikan et al. [17]p r o p o s e da
modified pediatric RIFLE (pRIFLE) classification in which
similar criteria were used for pediatrics. The main differ-
ence is a lower cutoff SCr to achieve the F category to
reflect that, because children have a lower baseline SCr, a
SCr of 4.0 mg/dl is not needed to cause severe dysfunction
(Table 1).
These classification systems to define AKI in neonatal
populations have not been performed. Large prospective
Table 1 Proposed working definitions for the classification of AKI in
adults and children. In all three classifications either creatinine or
urine output criteria suffice in staging (AKIN Acute Kidney Injury
Network, Cr creatinine, GFR glomerular filtration rate, eCCl
estimated creatinine clearance, SCr serum creatinine, ESRD end-stage
renal disease)
Adult Pediatric
AKIN AKIN/RIFLE RIFLE pRIFLE
Stage Serum Cr Urine output Class Serum Cr or GFR Class eCCl by Schwartz
formula
Urine output
I ↑ SCr >0.3 mg/dl or ↑ SCr
>150–200% from baseline
<0.5 ml/kg per
hour×6 h
Risk ↑SCr by 150% or GFR
decrease by 25%
Risk eCCl decrease by 25% <0.5 ml/kg per
hour×8 h
II ↑ SCr to >200-300% from
baseline
<0.5 ml/kg per
hour >12 h
Injury ↑ SCr by 200% or GFR
decrease by 50%
Injury eCCl decrease by 50% <0.5 ml/kg per
hour×16 h
III ↑ SCr of >300% from
baseline or SCr > 4.0 mg/dl
with an acute rise of at least
0.5 mg/dl
<0.3 ml/kg per
hour >24 h or
anuria for
>12 h
Fail ↑ SCr by 300% or SCr >
4.0 mg/dl with acute rise
of 0.5 mg/dl or GFR
decrease by >75%
Fail eCCl decrease by 75%
or <35 ml/min per
1.73 m
2 body
surface area
<0.3 ml/kg per hour
for 24 h or anuric
for 12 h
Loss Failure > 4 weeks Loss Failure > 4 weeks
ESRD Failure >3 months ESRD Failure >3 months
AKIN classification: an abrupt (within 48 h) reduction in kidney function required (adapted with permission [16])
RIFLE staging: R, I and F represent increasing stages of AKI (reproduced with permission [11])
pRIFLE eCCl based on Schwartz formula (reproduced with permission [17])
266 Pediatr Nephrol (2009) 24:265–274studies to test these classification models in neonatal AKI
are greatly needed to better understand the impact of AKI
on outcomes.
Diagnosis of acute kidney injury
Despite these working classification systems, the diagnosis
of AKI is problematic, as current diagnoses rely on two
functional abnormalities: functional changes in serum
creatinine [marker of glomerular filtration rate (GFR)] and
oliguria. Both these are late consequences of injury and not
markers of the injury itself. The ideal marker to detect AKI
should be up-regulated shortly after an injury and be
independent of GFR level. SCr is the most common
method to monitor renal function and to diagnose AKI,
but it has significant shortcomings including:
– SCr concentrations may not change until 25–50% of
the kidney function has already been lost, and, thus, it
may take days before a significant rise in SCr is seen.
– At lower GFR, SCr will overestimate renal function
due to tubular secretion of creatinine.
– SCr varies by muscle mass, hydration status, age and
gender.
– Different methods (Jaffe reaction vs enzymatic) pro-
duce different values, and medications and bilirubin
can affect SCr measurements by the Jaffe method [18,
19].
– Once a patient receives dialysis, SCr can no longer be
used to assess kidney function, since SCr is easily
dialyzed.
Additional problems with using SCr as a measure of AKI
specific to neonates include:
– SCr in the first few days of the neonate’s life reflects
the mother’s and not the infant’s renal function.
– Normal nephronogenesis in healthy term infants begins
at 8 weeks of gestation and continues until 34 weeks of
gestation, at which time the number of nephrons, 1.6–
2.4 million, approximates that of an adult [20].
Dependent on the degree of the neonate’s prematurity,
GFR steadily improves from 10–20 ml/min per 1.73 m
2
body surface area during the first week of life to 30–40
ml/min per 1.73 m
2 by 2 weeks after birth, concomitant
with alterations in renal blood flow. Thereafter, GFR
improves steadily over the first few months of life [21]
(summarized by Schwartz et al. [22]; Table 2).
– Overall GFR in term and preterm infants is very low,
and there is a very wide distribution of normal serum
creatinine values, which vary greatly, dependent on
level of prematurity and age [23] (Fig. 1).
– Bilirubin levels in premature infants are normal at birth,
rise in the first several days and return to normal after a
few weeks. If the Jaffe method of SCr is used, this may
have tremendous impact on the interpretation of SCr
[18].
Owing to the challenges outlined above, our ability to
define AKI reliably is very difficult in the neonatal
Fig. 1 Plasma creatinine in neo-
nates (reproduced with permis-
sion from [23])
Table 2 Inulin clearance GFR in healthy premature infants (adapted
with permission from [22])
Age Clearance (ml/min
per 1.73 m
2)
Pre-term infants
1–3 days 14.0±5
1–7 days 18.7±5.5
4–8 days 44.3±9.3
3–13 days 47.8±10.7
1.5–4 months 67.4±16.6
Term infants
1–3 days 20.8±5.0
4–14 days 36.8±7.2
1–3 months 85.3+35.1
4–6 months 87.4±22.3
7–12 months 96.2+12.2
1–2 years 105.2±17.3
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injury biomarkers (in addition to functional markers such as
GFR and urine output) which can ultimately predict
morbidity and mortality rates is of paramount importance.
Until well-designed clinical research studies on AKI
definitions have been completed, our ability to recognize
and design studies on prevention and treatment in neonates
with AKI will be very difficult.
Epidemiology of neonates with acute kidney injury
Critically ill neonates are at risk of having AKI, as they are
commonly exposed to nephrotoxic medications and have
frequent infections that lead to multi-organ failure [4]. The
exact incidence of neonatal AKI is unknown, but it is likely
higher than is reported, as infants very commonly have non-
oliguric renal failure. In addition, most studies that describe
neonatal AKI use high levels of serum creatinine or need for
dialysis to define AKI, which may miss a significant number
of infants according to the currently proposed definitions in
adults and pediatric populations (Table 1)[ 5, 24]. Moghal
et al. [25] suggested that, relative to other critically ill
populations, neonatal AKI has the highest incidence
(Fig. 2). Published studies estimate that the incidence of
AKI in critically ill neonates is between 8% and 24% and
that mortality rates are between 10% and 61% [4].
Most studies on neonates with AKI describe term infants
with asphyxia at the time of birth (Table 3). Hypoxic-
ischemic encephalopathy (HIE) accounts for 23% of the 4
million neonatal deaths globally and high rates of disability
[27]. Three different observational studies describe the
incidence of AKI in this subset of critically ill newborns.
Karlowicz and Adelman [6] compared term infants with
severe asphyxia (according to the Portman asphyxia
morbidity scoring system [28]) with similar infants with
moderate asphyxia scores. They found that AKI (SCr >1.5
mg/dl) occurred in 20/33 (66%) of infants with severe
asphyxia compared with 0/33 (0%) in those with moderate
asphyxia. In a case–control analysis (matching for gesta-
tional age and birth weight in otherwise healthy newborns)
Aggarwal et al. [3] showed that the incidence of AKI in
infants with 5 min Apgar scores ≤6 was 56% vs 4% in
controls. They noted that clinical markers of asphyxia were
better predictors of adverse outcomes than were renal
function tests. Similarly, Gupta et al. [2] found a 47%
incidence of AKI and 14.1% mortality in infants with
Apgar scores ≤6. All these studies report over 50% of AKI
cases to be non-oliguric, which highlights the insensitivity
of oliguria to predict AKI in neonates.
Two recent studies have explored AKI in the general
critically ill neonatal population and confirm high inciden-
ces of AKI and deaths in these infants. In a retrospective
analysis, Agras et al. [5] found a 25% hospital mortality
rate in neonates with AKI. Many (47%) of their patients
had non-oliguric renal failure and premature infants
constituted 31% of the cases. This retrospective study is
limited, because many infants did not have their SCr
measured during potential AKI. Mathur et al. [8] prospec-
tively studied mostly term neonates with sepsis and found a
26% incidence rate of AKI. The mortality rate was
significantly higher in those with AKI than in those with
no AKI (70.2% vs 25%, P <0.001). Although this study
gives insight into the incidence of AKI in neonates, it is
limited by the authors’ definition of AKI [blood urea
nitrogen (BUN)>20 mg/dl] and their inability to control for
gestational age, birth weight, co-morbidities and severity of
illness. Because of limitations in study design, one must use
caution in making solid inferences about the true incidence
and outcomes after neonatal AKI based on these studies.
Large observational studies of adults have convincingly
shown that AKI independently predicts hospital length of
stay, short and long-term survival in adults with AKI, once
co-variables and complications have been carefully adjust-
ed [12, 14, 15, 29–33]. In a meta-analysis, Ricci et al. [34]
systematically reviewed all published articles on RIFLE that
adjusted for co-morbidities and severity of illness. Compared
with patients that did not have AKI, those with risk, injury,
and failure had an adjusted relative risk (RR) of 2.4, 4.15,
and 6.37, respectively (P <0.0001 for all) (Table 4). Recently
Akcan-Arikan applied AKI classification to children who
required blood pressure or ventilator support and found that
80% had developed AKI under this classification. Those
with a maximum RIFLE score for R had an adjusted odds
ratio (OR) for death of 2.9 (0.8–10.9); those with RIFLE of I
or F had an adjusted OR of 3.0 (1.1 to 8.1) [17].
One of the most common sequelae of prematurity is the
propensity to develop bronchopulmonary dysplasia (BPD), as
it affects 10% and 40% of surviving very low birth weight
infants and extremely low birth rate infants, respectively [35].
The pathophysiology of this chronic lung condition involves
elevated levels of pro-inflammatory interleukins, tumor
necrosis factor-α (tnf-α), leukotrienes, and increased perme-
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Fig. 2 Age-related comparative yearly incidence of AKI (adapted
with permission from [25])
268 Pediatr Nephrol (2009) 24:265–274ability of pulmonary vasculature, which culminate in abnor-
mal lung development and fibrosis. Not only does AKI cause
pulmonary edema secondary to volume overload, but also
evidence from animal models of ischemic, nephrotoxic and
bilateral nephrectomy shows that AKI induces a pro-
inflammatory process highlighted by increased levels of
neutrophils, tnf- α, interleukins, free radicals, endothelial
growth factors and granulocyte colony stimulating factor [36–
38]. Clinically, it has been recognized that not only do
ventilated critically ill adults with AKI have a dismal
prognosis (80% mortality rate) but they also have an impaired
ability to be weaned from mechanical ventilation [31]. To
date, little is known about the lung–kidney interactions in
premature infants or the role the kidney has in BPD.
Alargeprospectivecohort studywithaccepteddefinitions
is greatly needed to help us better understand the incidence
and independent impact of AKI on asphyxiated infants,
premature infants, infants undergoing cardiopulmonary
bypass and the general critically ill newborn populations.
The role that the kidney plays in acute and chronic
pulmonary diseases in premature infants needs to be
explored.
Novel early biomarkers of acute kidney injury
Because the incidence of AKI continues to rise, while the
outcomes remain poor, nephrologists and intensivists
Table 3 Original articles on AKI in neonates (GA gestational age, BUN blood urea nitrogen, NICU neonatal intensive care unit, UOP urine
output, DIC disseminated intravascular coagulation)
Author Type of
study
Cases Controls Definition
of AKI
Findings Comments
Karlowicz
and
Adelman
(1995)
Prospective
case–control
33 infants ≥ 36 weeks
GA and 5 min Apgar
scores ≤6 with severe
asphyxia scores
33 infants ≥ 36 weeks
GA and 5 min Apgar
scores ≤6 with
moderate asphyxia
scores
SCr >
1.5 mg/dl
AKI occurred in 61% of
those with severe
asphyxia and 0% in
those with moderate
asphyxia
Agras et
al. (2004)
Retrospective
chart review
45 term and preterm
infants. Excluded
cardiac
none SCr >
1.5 mg/dl
Incidence; term=3.4%
Premature infants=31%
Non-oliguric=40%
Asphyxia=40%
Mortality=24.4%
Aggarwal
et al.
(2005)
Prospective
case–control
25 infants ≥ 34 weeks, 5
min Apgar scores ≤6.
Exclude those on
diuretics or
nephrotoxins
25 matched (GA and
birth weight) infants
SCr >
1.5 mg/dl
AKI incidence: cases
56%, controls 4%
Clinical markers of
asphyxia were better
predictors of adverse
outcome than were
renal function tests
Apgar scores ≤6 pick
up most cases of
renal failure
Gupta et
al. (2005)
Prospective
case–control
70 infants with 5 min
Apgar scores ≤6
28 healthy controls SCr >
1.5 mg/dl
AKI incidence: cases=
47.1%, controls 0%
78% of AKI
non-oliguric
Hospital mortality:
cases=14.1% vs ?
Mathur et
al. (2006)
Prospective
case–control
52 infants with sepsis 146 infants with
sepsis
BUN >
20 mg/dl
on two
occasions
AKI incidence: cases=
52/200 (26%)
Those with AKI more
likely to have shock,
DIC, meningitis and
prematurity
Hospital mortality:
AKI=70.2% vs no
AKI=25%
Chevalier
et al.
(1984)
Descriptive
observational
16 infants referred to
pediatric nephrology
service
none SCr >
1.5 mg/dl
Hospital mortality=25%
Non-oliguric renal
failure had better
outcomes
Norman
and
Asadi
(1979)
Descriptive
observational
72/314 NICU
admissions
none BUN >
20 mg/dl and
or UOP <
1 ml/kg per
hour
Incidence of AKI 23%
52/72 responded to
fluids
20/72 had no response
to fluids
Mortality: 9/20 (45%)
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improvement of outcomes. Recent advances in the field
of early AKI biomarkers have provided great optimism.
Novel urine and serum biomarkers may change our
approach to this condition if they can indicate AKI hours
after an insult, in comparison with the days it may take
serum creatinine to rise substantially. As opposed to our
current functional markers of AKI (GFR and urine output),
these biomarkers promise to signal injury early in the
disease process, and, hopefully, they will allow us to
intervene in the disease process at the onset of acute kidney
‘injury’ as opposed to attempting to fix acute kidney
‘failure’ [39, 40].
Biomarkers are currently being explored to differentiate
between different causes of established AKI, to detect AKI
early, and to prognosticate outcomes. Currently, the most
promising early non-invasive biomarkers of AKI are serum
and urinary neutrophil gelatinase-associated lipocalin
(NGAL) [41], urinary interleukin-18 (IL-18) [42], kidney
injury molecule-1 (KIM-1) [43, 44], and serum cystatin C
[40]. Normal values in children are available [45] (Fig. 3).
Many others continue to be explored, but they are beyond
the scope of this review (see Coca et al. [46] and Nguyen
and Devarajan [47] for reviews).
NGAL is one of the most strikingly up-regulated genes
and over-expressed proteins in the kidney after ischemia
[41]. Serum and urinary levels are elevated in human
models of AKI, including neonates undergoing cardiopul-
monary bypass surgery [48] (Fig. 4) and in a heterogeneous
critically ill pediatric population [50, 51].
Lavery et al. recently examined 20 premature infants
(divided into four birth weight categories with five subjects
each) and looked at baseline urinary NGAL. They found
that levels inversely correlated with both birth weight and
gestational age. The wide baseline ranges narrowed over
the course of 14 days [52], likely due to ongoing renal
development. This finding is likely to be present for other
biomarkers; thus, one of the challenges in our finding
neonatal AKI biomarkers will be to account for the changes
in renal developmental that will be present.
IL-18 urine levels are elevated in adults with ischemic
AKI compared with other causes of renal injury, including
urinary tract infection, nephrotic syndrome and chronic
renal failure [49]. IL-18 levels are also elevated in neonates
with AKI [42] following cardiopulmonary bypass (Fig. 4).
In pediatric critically ill populations, IL-18 levels were
significantly elevated early in those without sepsis and
AKI, but not in those with sepsis [51, 53]. This highlights
our need to test these biomarkers in different populations
under different clinical scenarios.
Fig. 3 Box plot distribution
showing cystatin C across age
groups. The categories 24–28
weeks and 29–36 weeks refer to
the gestational age of preterm
babies. Preterm babies were 1
day old when the samples were
drawn (reproduced with permis-
sion [45])
Table 4 The RIFLE criteria and mortality rates for adults with acute
kidney injury (adopted with permission from [34]) (95% CI 95%
confidence interval)
Compared AKI
levels
No. of
studies
Adjusted
RR
95% CI P (overall
effect)
Risk vs non-AKI 13 2.4 1.94, 2.97 <0.00001
Injury vs non-AKI 13 4.15 3.14, 5.48 <0.0001
Failure vs non-AKI 13 6.37 5.14, 7.90 <0.0001
270 Pediatr Nephrol (2009) 24:265–274NGAL, IL-18, KIM-1 cystatin C and many other
biomarkers have been developed and are undergoing
intensive testing in pediatric and adult critically ill
populations. These non-invasive biomarkers of AKI need
to be tested in the subsets of the critically ill neonatal
population. In premature infants, baseline biomarkers may
be changing during extra-uterine renal development, which
will create additional challenges in the discovery of
biomarkers of AKI in this population. Use of multiple
markers together may better define the cause of AKI and
provide information as to the time of injury. Improving our
ability to diagnose AKI early in the disease process is an
essential first step prior to implementing preventive and
therapeutic interventions to improve outcomes.
Neonates with acute kidney injury are at risk
of developing chronic kidney disease
Premature infants have impaired glomerulogenesis which is
more pronounced in those with acute kidney injury.
Using computer assisted morphometry, Rodriguez et al.
measured radial glomerular counts (RGCs) in autopsied
kidneys of premature infants with short vs long survival.
They obtained the RGCs by counting the layers of
glomeruli, following a straight line beginning in the deepest
zone of the cortex and progressing systematically to the
renal capsule, in well-oriented areas. They found that
premature infants who had died early during their hospital-
ization had lower RGCs than term infants had. Premature
infants who survived to the 40-week gestational (term) age
had RGCs similar to those of premature infants with shorter
survival, thus suggesting that the extra-uterine environment
does not allow for proper neo-glomerulogenesis. In addi-
tion, infants with AKI had lower RGCs than did similar
infants without AKI, suggesting that injury during this
critical time can have substantial implications for total
nephron counts [9]. Recently, Iacobelli et al. showed that, at
a 6-year follow-up, premature infants with neonatal
hypotension were at higher risk of microalbuminuria [54].
The authors were not able to correlate microalbuminuria to
AKI, due to their study design.
Low nephron mass leads to chronic kidney disease
The filtration rate of single nephrons and the number of
nephrons present determine total GFR. When the number of
nephrons is diminished, single-nephron GFR increases as
the kidney works to compensate. This compensatory
hypertrophy causes the glomeruli to function under in-
creased intracapillary hydraulic pressure, which, over time,
causes damage to the capillary walls. This abnormal
process leads to progressive glomerulosclerosis, protein-
uria, hypertension and chronic kidney disease [55]. The
hyperfiltration hypothesis has been applied to, and con-
firmed in, autopsy data from hypertensive patients [56, 57]
and in infants with intrauterine growth retardation (IUGR)
[58–62].
Acute kidney injury predicts/results in chronic kidney
disease injury
Although most survivors of AKI have improved glomerular
and tubular function prior to hospital discharge, long-term
renal injury has been documented in children with
congenital heart diseases [63], Henoch–Schönlein purpura
[64], very low birth weight neonates [10] and hemolytic
uremic syndrome [65]. The exact incidence of CKD after
AKI is unknown, although growing data suggest that the
incidence of CKD and mortality rates are high after AKI in
adults [15, 66, 67]. We recently showed that, after pediatric
AKI, the mortality rate is high in the years after hospital
discharge. In addition, over 50% of children have at least
one sign of CKD 3–5 years after the initial event [68].
Animal models have shown a clear relationship between
AKI and long-term CKD caused by damage to endothelial
vascular cells progressing to fibrosis and loss of function
[69]. What is not known from these studies is the extent to
which AKI leads to CKD in human populations, as it is
unclear how often co-morbid conditions and pre-existing
CKD are present before the hospitalization. Studying the
long-term effects of AKI on CKD in neonates is ideal, as
the causes of AKI and co-morbidities are more easily
deciphered than in adults, where confounding diseases such
Fig. 4 Pattern of urinary IL-18 and NGAL levels after cardiopulmo-
nary bypass. AKI (defined as a > 50% increase in serum creatinine)
developed after 48–72 h in the AKI patients (reproduced with
permission from [49])
Pediatr Nephrol (2009) 24:265–274 271as atherosclerosis, diabetes and smoking can all contribute
to the events causing both AKI and CKD. Causal insights
and strategies to prevent progression of CKD after AKI
could have lasting effects on children and adults after AKI.
Future directions
Numerous resources have been expended to improve our
understanding of the pathophysiology, to test definitions
and classification systems, and to develop non-invasive
urinary biomarkers of AKI. Neonates have unique charac-
teristics that challenge our ability to understand AKI in
these populations and yet they are, in many ways, an ideal
population to study because they lack the co-morbid and
pre-existing problems that confound our understanding of
how AKI affects outcomes. Because of the many shortfalls
of using changes in SCr to diagnose AKI, the pediatric
nephrology community needs to conduct studies to find
better methods to diagnose neonatal AKI. Clear definitions
which can predict hard endpoints need to be constructed.
Epidemiologic studies to better understand the exact
incidence and short- and long-term outcomes in this
population are greatly needed. The kidneys’ role in
systemic end-organ disease needs to be explored. Once
these research questions have been answered, multi-center
intervention studies to improve the short- and long-term
outcomes in this vulnerable population can be performed.
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Self assessment questions:
(Answers appear following the reference list)
1. Oliguria in term asphyxiated infants is a sensitive sign
of AKI.
a. True
b. False
2. Asphyxiated infants with Apgar scores >7 are unlikely
to have AKI.
a. True
b. False
3. Serum creatinine is not an ideal marker of AKI in
neonates for the following reasons:
a. It reflects maternal creatinine in the first few days
of life
b. There is a wide distribution, which varies by age
and level of maturity
c. If the Jaffe method is used to measure creatinine,
changing levels of bilirubin can alter reported levels
d. All of the above
4. Early biomarkers of AKI in neonates
a. Are unlikely to have any role in the diagnosis of
neonatal AKI
b. Discovery will have additional challenges including
differences in baseline levels of markers dependent
on age and gestational age
c. Are currently being used to diagnose neonatal AKI
early in the disease process
d. Cannot be used in urine due to the massive
quantities needed for analysis
5. Premature infants with AKI should be followed for
long-term consequences of CKD.
a. True
b. False
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